Market News

Breaking headlines and analysis across every asset class.

Markets
Kalkine Media • Sep 1, 2026
Why Is Southern Company Getting Attention?

Southern Company (NYSE:SO) is currently gaining market attention due to its recent operating update on regulated utility priorities. As an electric and gas utility company, its communication regarding operational efforts and strategic direction is significant for market participants. The update provides qualitative signals about the company's focus and execution in the context of broader industry themes like customer selectivity and changing demand patterns.

Markets
Yahoo Finance • Sep 1, 2026
Jim Cramer Tells Mad Money Caller Why Netflix (NFLX) Is Worth a Moderate Buy

Jim Cramer advised a "moderate buy" on Netflix (NFLX) despite recent leadership missteps, including a botched buyout attempt and Reed Hastings stepping down. He acknowledged market anxiety about capital allocation but highlighted Netflix's strong financial results, with $12.56 billion in Q2 revenue and ambitious plans for $3 billion in advertising revenue by 2026. While institutional backing slightly decreased, Cramer believes the company's content execution can offset strategic issues, making i

Markets
Kalkine Media • Sep 1, 2026
Why Does News Corp's (ASX:NWS) Repurchase Program Exclude ASX Holders?

News Corporation (ASX:NWS) has clarified that its share repurchase program applies exclusively to its Nasdaq-listed shares, explicitly excluding Australian holders of Chess Depository Interests (CDIs) from participating. This distinction is crucial for local investors, highlighting the unique cross-market structure of the global media group. The disclosure emphasizes that corporate actions like this repurchase can be tailored to the primary listing, even for companies with a broad international

Markets
MarketBeat • Sep 1, 2026
Edwards Lifesciences (NYSE:EW) SVP Sells 544 Shares of Stock

Andrew Dahl, SVP of Edwards Lifesciences (NYSE:EW), sold 544 shares of the company's stock for approximately $49,537, reducing his stake by 3.53%. This insider sale comes as Edwards Lifesciences reported strong quarterly earnings, beating EPS estimates by $0.04 and seeing revenue increase by 13.6% year-over-year. Analysts currently hold a "Moderate Buy" consensus rating for the stock, with an average price target of $100.27.

Markets
Kalkine Media • Sep 1, 2026
Edwards Lifesciences SVP Andrew M. Dahl Sells 544 Shares Under Employee Stock Purchase Plan

Andrew M. Dahl, Senior Vice President and Corporate Controller at Edwards Lifesciences Corp, sold 544 shares of common stock at $91.055 per share on August 31, 2026, under the company's Employee Stock Purchase Plan. Following this transaction, Dahl directly owns 14,868.41 shares of Edwards Lifesciences. This transaction was disclosed via an SEC Form 4 and reflects routine quarterly share acquisitions.

Markets
Reuters • Sep 1, 2026
Boeing, engineers union to resume contract negotiations on Sept 8, union says

Boeing and the Society of Professional Engineering Employees in Aerospace (SPEEA) will resume contract talks on September 8th. This comes after SPEEA members overwhelmingly rejected Boeing's previous four-year contract offer on August 21st, with their primary demand being higher general wage increases. Boeing has expressed its commitment to reaching a resolution that benefits employees and maintains the company's competitiveness.

Get Headlines in Your Inbox

One email a day with the market-moving stories you actually need to read.